Hepatitis C virus (HCV)-related end-stage liver disease represents the primary indication for liver transplantation in Western countries, but is associated with poor posttransplantation outcomes and a rapid progression of HCV-related disease. This article reviews the risk factors underlying this association and presents the current strategies used to manage HCV infections in transplant recipients.
Angelico, M. (2011). Epidemiology and outcome of hepatitis C relapse in transplant recipients. TRANSPLANTATION PROCEEDINGS, 43(6), 2457-2458 [10.1016/j.transproceed.2011.06.016].
Epidemiology and outcome of hepatitis C relapse in transplant recipients
ANGELICO, MARIO
2011-01-01
Abstract
Hepatitis C virus (HCV)-related end-stage liver disease represents the primary indication for liver transplantation in Western countries, but is associated with poor posttransplantation outcomes and a rapid progression of HCV-related disease. This article reviews the risk factors underlying this association and presents the current strategies used to manage HCV infections in transplant recipients.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.